UnitedHealth Group Incorporated (UNH) 株式分析

企業概要

UnitedHealth Group Incorporated operates as a comprehensive healthcare enterprise serving both the United States and international markets through a diversified portfolio of segments. The organization functions within the Healthcare sector, specifically the Healthcare Plans industry, which encompasses the management of medical insurance and related services. The company demonstrates substantial scale with a market capitalization of 2777.3B 円 (approximately 277.73B USD) and an annual revenue of 4475.7B 円 (approximately 447.57B USD), employing approximately 390,000 individuals globally. These valuation and revenue figures indicate that UnitedHealth Group holds a dominant position within the global healthcare infrastructure, acting as a critical intermediary between providers, payers, and consumers. The breadth of its operations across four distinct segments further underscores its role as a systemic pillar in the delivery of care, wellness, and pharmaceutical services.

財務健全性

The company reported a total revenue of 4475.7B 円 (approximately 447.57B USD) for the trailing twelve months, with net income standing at 120.6B 円 (approximately 12.06B USD) and EBITDA reaching 216.2B 円 (approximately 21.62B USD). The significant disparity between the 4475.7B 円 revenue and 120.6B 円 net income reveals a substantial cost structure comprising operational expenses, claims payments, and administrative overhead inherent to the healthcare industry. UnitedHealth Group generated free cash flow of 138.6B 円 (approximately 13.86B USD), which provides the financial flexibility necessary for capital allocation, debt servicing, and potential strategic investments without relying on external financing. The company maintains a cash balance of 281.2B 円 (approximately 28.12B USD) against total debt of 830.0B 円 (approximately 83.00B USD), resulting in a debt-to-equity ratio of 81.62, which suggests a highly leveraged balance sheet relative to equity. While the current ratio stands at 0.79, indicating that current assets are lower than current liabilities and suggesting tight short-term liquidity management, the firm manages these obligations through its robust cash generation capabilities. Return on Equity is 12.5% and Return on Assets is 3.9%, metrics that reflect the efficiency with which management utilizes shareholder capital and total assets to generate profits.

バリュエーション評価

The valuation metrics show a trailing P/E ratio of 23.15 compared to a forward P/E of 15.22, implying that the market expects earnings to recover or grow significantly in the future to justify the current price. The price-to-book ratio is 2.95, indicating that the market values the company at nearly three times its book value, reflecting a premium assigned to its intangible assets and growth prospects. Alternative valuation measures include a price-to-sales ratio of 0.62 and an EV/EBITDA of 15.73, which suggest the company is valued at less than one dollar of sales per dollar of revenue, potentially indicating value relative to its sales volume. The stock has traded between a 52-week low of 234.60 円 and a 52-week high of 606.36 円, with the current price position fluctuating within this established historical range. The beta value is 0.41, which signifies that the stock's price volatility is less than half that of the broader market, making it a relatively defensive holding during periods of market turbulence.

Growth & Income

Revenue growth year-over-year is recorded at 12.3%, whereas earnings growth year-over-year is -99.9%, indicating a sharp contraction in profitability relative to top-line expansion. This divergence suggests that while the company is expanding its operational reach, net income has been negatively impacted, possibly by one-time charges, restructuring costs, or margin compression in specific segments. As a dividend payer, UnitedHealth Group offers a dividend yield of 2.9% with a payout ratio of 66.0%, meaning the company distributes roughly two-thirds of its earnings to shareholders. Given the recent negative earnings growth, the sustainability of this payout ratio requires careful monitoring as it exceeds the current level of retained earnings available for distribution. The overall profile presents a complex picture of a large-scale entity with strong revenue expansion but significant headwinds affecting current earnings and dividend sustainability.